China is crushing half of India's chemical industry — and hiring the other half
We read all 28 earnings calls Indian chemical companies held this results season. One country came up more than any other — as the reason profits collapsed, and as the reason order books are full. Which side of that line a company sits on decided this quarter's winners, and will likely decide the next few years.
28
Chemical earnings calls read15
Talked about China+9% to +31%
Contracted-growth side−2% to −15%
Price-spike sideEvery results season has a theme hiding in the earnings calls. This season, in chemicals, it was one country. Chinese factories came up on call after call — sometimes as the reason an Indian company's prices are collapsing, sometimes as the reason its order book is full for three years. The remarkable part: both stories are true at the same time. China's chemical overcapacity is flooding world markets with cheap commodity product. And precisely because of that dominance, the world's big buyers of specialty chemicals are deliberately hiring suppliers outside China — a strategy the industry calls China-plus-one — and India is the supplier being hired. Which side of this line a company sits on decided this quarter's stock reactions almost by itself.
One force, two fates
On the losing side, China is the competitor. Tata Chemicals told investors that Chinese soda ash inventories are at all-time highs and that its US exports to Southeast Asia are now running at a loss until Chinese capacity rationalizes — pricing is expected to stay weak through the year. PVC makers described spreads underwater against Chinese imports, protected only by temporary import duties. Agrochemical companies pointed to cheap Chinese generics delaying their new product launches. When China makes what you make, this is what the quarter looked like.
On the winning side, China is the customer's problem. A global fragrance house or an American battery maker that sources 95% of an ingredient from China now sees that as a board-level risk — so it qualifies a second supplier, signs a multi-year contract, and often pays a premium for the security. Those contracts landed in India, and this season they showed up in the numbers.
The evidence of being hired
Privi Speciality — the 95% ingredient
Neogen Chemicals — hired by law
Laxmi Organic — the shutdown shift
Yasho Industries — contracts, not spot
Beyond chemicals
The market already voted
Read the first and last rows together. TANFAC fell 6% on results day — the quarter itself was hurt by a cost lag — and is up 31% since, because its new refrigerant plant is 65% pre-sold before it even commissions. PCBL jumped 15% on results day and has fallen 15% below its starting point since, because management admitted on the call that most of the beat was an inventory gain that reverses this quarter. The market did not pay for the size of the quarter. It paid for the source of it.
How to tell which side a company is on
- 1
Did volumes grow, or just prices?
Yasho's 55% growth carried 42 points of volume. Laxmi's 40% growth carried 10. Price-led growth in a commodity chemical is the cycle, not the company.
- 2
Are sales contracted or spot?
Multi-year formula-priced contracts, pre-sold capacity, customer-funded qualification — these survive a price normalization. Spot spreads do not.
- 3
Is China the competitor — or the customer's problem?
If the company makes what China floods, its pricing floor is Beijing's capacity discipline. If it makes what buyers want a non-Chinese source for, that same dominance is its order book.
- 4
What did management raise guidance on?
Customer commitments and capacity coming online — or a spike they themselves call temporary? The most-asked analyst question on these 28 calls, pressed on eight of them, was: how much of this margin is one-off, and when does it reverse.
What we are watching
September
Privi's expanded capacity commissions after a three-month delay; first read on whether the maltol entry converts to orders.
October–December
The contracted ramps get real: Himadri's first battery-materials phase, TANFAC's refrigerant plant, Neogen's US battery-salt shipments. Each one either validates the pre-sold story or tests it.
The commodity floor
Anti-dumping cases and import-duty decisions on PVC and soda ash set the floor for the competing-with-China half. Until Chinese capacity rationalizes, their managements say pricing stays weak.
Next quarter's margins
The price-spike cohort's own guidance implies normalization — PCBL quantified the reversal. September-quarter results will show whether the market's skepticism was right.
None of this is a recommendation. It is a record of what 28 managements said about the same force in the same month, and how the market priced the difference. The lens is the takeaway: when a sector's results look uniformly strong, ask what each company's quarter was made of — and whether the country dominating its industry is its competitor, or its customer's reason to call.
The calls run again in October.
Informational and educational content only. Not investment advice.